Michael Kaseta
COO & CFOMr. Michael Kaseta, also known as Mike, is Independent Director of Heron Therapeutics, Inc. from November 2024. Mr. Kaseta serves as Director of Bryn Pharma, LLC from May 2023. He serves as Independent Director of Alimera Sciences, Inc. since March 2023. He serves as Chief Financial Officer at Liquidia Corporation since November 30, 2020 and also serves as its Chief Operating Officer since January 15, 2024. Mr. Kaseta had been Chief Financial Officer of Aerami Therapeutics Holdings, Inc. since January 21, 2019 until November 2020. Mr. Kaseta had been Chief Financial Officer of Aralez Pharmaceuticals Inc. since March 13, 2018 until January 18, 2019. Mr. Kaseta served as Head of Finance and Interim Chief Financial Officer of Aralez Pharmaceuticals Inc. from November 30, 2017 to March 2018 and Corporate Controller from September 26, 2016 to November 2017. Prior to joining Aralez, Mr. Kaseta served as the Chief Financial Officer of Sanofi North America, Global Services from April 2015 to September 2016. Mr. Kaseta was the Vice President Sanofi NA Pharma Controlling from January 2013 to April 2015, Vice President of Sanofi Financial Shared Services from March 2007 to December 2013 and Director of Technical Accounting from 2005 to 2007. He has a breadth of experience in all aspects of the financial operations. Mr. Kaseta holds a BBA in accounting from James Madison University and is a CPA (inactive) licensed in the state of New Jersey.
Positions
- Company NameLiquidia CorporationStock CodeLQDAPositionCOO & CFOColleagues
- RARoger A. JeffsCEO & Director
- SMStephen M. BlochIndependent Chairman
- RSRussell SchundlerChief Strategy Officer, General Counsel & Corporate Secretary
- SMScott MoomawChief Commercial Officer
- RSRajeev SaggarChief Medical Officer
- ASArthur S. KirschIndependent Director
- JCJoanna Caroline HorobinIndependent Director
- RSRamandeep SinghIndependent Director
